Plaintiffs and Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, Agree to Resolve All Gender Discrimination Claims Associated With Class Action
July 14th, 2010
Plaintiffs and Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, agree to resolve all gender discrimination claims associated with class action Agreement reached between Novartis Pharmaceuticals Corporation (NPC) and Class Plaintiffs – company to make monetary payment of up to USD 152.5 million to eligible class members As part of its commitment to fostering […]
Novartis Class Awarded $250 Million in Punitive Damages
May 19th, 2010
Verdict Is Strong Rebuke to Pharma Giant’s Gender Discrimination. Sparks Hope for Change in Company’s Treatment of Female Sales Reps For more information, contact Jamie Moss, newPRos, 201-493-1027; jamie@newspros.com (May 19, 2010, New York City) –After delivering a unanimous verdict against Novartis on all counts and awarding 12 former Novartis sales reps $3.36 million in […]
Female Sales Reps Win Case Against Novartis in Largest Gender Discrimination Case to go to Verdict
May 17th, 2010
Jury Says Pharma Giant Discriminated Against Women Will Decide Punitive Damages Tomorrow For more information, contact Jamie Moss, newPRos, 201-493-1027; jamie@newspros.com (May 17, 2010, New York City) – A New York jury handed Novartis Pharmaceuticals a bitter pill today, finding the giant drug maker guilty of gender discrimination in pay, promotional opportunities and pregnancy-related matters. […]
Novartis Gender Discrimination Trial Begins Today
April 7th, 2010
5600 Female Employees Seek $200M for Disparities in Pay and Promotion & Pregnancy Discrimination For more information, contact Jamie Moss, 201-493-1027 (April 7, 2010, New York) — Jury selection begins today in what is believed to be one of the largest gender discrimination class actions ever to go to trial in the U.S. Over 5600 […]
Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation
March 11th, 2010
Physicians and Hospitals Get Kickbacks and Other Incentives Manufacturers Promoting Off-Label, Unapproved Cardiac Surgery Using Their Devices For more information, contact Jaime Baum, 847 502 3825, JBaumPR@gmail.com (March 11, 2010, Washington, D.C.) – As reported in today’s Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the […]
